Vaccines Media ArticlesExcerpts of Key Vaccines Media Articles in Major Media
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
The mother of a Cheshire teenager who was left severely brain damaged by the MMR vaccine has won a compensation award from the government. Robert Fletcher, 18, from Warrington, suffered a fit 10 days after he had the vaccination when he was 13 months old. His mother Jackie received the Ł90,000 payout from a medical assessment panel last week. The family successfully appealed after their application for compensation was originally turned down in 1997. Robert has frequent epileptic fits, is unable to talk, stand unaided or feed himself, but is not autistic. Mrs Fletcher always believed that her son's epilepsy was triggered by the combined measles, mumps and rubella vaccine. Dr Andrew Wakefield was the lead author of the controversial study, published in The Lancet in 1998, which suggested there may be a link between MMR and autism and bowel disease. His comments and the subsequent media furore led to a sharp drop in the number of children vaccinated against these diseases. The study has since been discredited and The Lancet has said it should not have run it. Mrs Fletcher has campaigned for justice for her son for the past 16 years. She said: "I feel vindicated by it because over the years I've been labelled anti-vaccine and a scaremonger and all sorts of things, when all I've been trying to do is highlight what's happened to my son, to help safeguard other parents' children."
Note: For lots more from major media sources on the dangers to children from vaccines, click here.
Despite months of dire warnings and millions in taxpayer dollars, less than half of the 229 million doses of H1N1 vaccine the government bought to fight the pandemic have been administered -- leaving an estimated 71.5 million doses that must be discarded if they are not used before they expire. Between 81 million and 91 million doses of swine flu vaccine were injected into peoples' arms or squirted up their noses through the end of February, according to federal officials, leaving about 138 million doses unused. An estimated 60 million of those will be donated to poor countries or saved for possible future use. But doses already in vials and syringes will be thrown away if not used before their expiration dates pass. The prospect of millions of doses of the once-precious vaccine being discarded is the latest twist in the $1.6 billion program -- the most ambitious immunization campaign in U.S. history. The government-led effort produced a vaccine in record time, but unexpected production problems delayed delivery of the bulk of supplies until after the second wave of infections had peaked.
Note: Yet the pharmaceutical companies get to keep the huge profits from the vaccines, paid for by the taxpayers. For key reports from major media sources on the government and pharmaceutical corporation corruption involving bird and swine flu vaccines, click here.
Federal health authorities recommended [on March 22] that doctors suspend using Rotarix, one of two vaccines licensed in the United States against rotavirus, saying the vaccine is contaminated with material from a pig virus. Rotarix, made by GlaxoSmithKline, was approved by the FDA in 2008. The contaminant material is DNA from porcine circovirus 1, a virus from pigs that is not known to cause disease in humans or animals. About 1 million children in the United States and about 30 million worldwide have gotten Rotarix vaccine. Rotavirus disease kills more than 500,000 infants around the world each year, primarily in low- and middle-income countries. Before rotavirus vaccine became available, the disease was blamed for more than 50,000 hospitalizations and several dozen deaths per year in the United States. "We're not pulling it from the market, we're just suspending its use during this period while we're collecting more information," [Food and Drug Administration Commissioner Dr. Margaret Hamburg] said.
Note: If you explore the vaccine approval process, you may be shocked to find how potentially dangerous materials added to vaccines are not tested for safety. A mercury-based derivative called Thimerosal is still allowed in many vaccines, including the recent swine flu vaccine that was given massively to populations around the world. For more reliable information on this, click here.
The risk of children suffering from flu can be halved if they take vitamin D, doctors in Japan have found. The finding has implications for flu epidemics since vitamin D, which is naturally produced by the human body when exposed to direct sunlight, has no significant side effects, costs little and can be several times more effective than anti-viral drugs or vaccine. Only one in ten children, aged six to 15 years, taking the sunshine vitamin in a clinical trial came down with flu compared with one in five given a dummy tablet. Mitsuyoshi Urashima, the Japanese doctor who led the trial, told The Times that vitamin D was more effective than vaccines in preventing flu. Vitamin D was found to be even more effective when the comparison left out children who were already given extra vitamin D by their parents, outside the trial. Taking the sunshine vitamin was then shown to reduce the risk of flu to a third of what it would otherwise be. The trial, which was double blind, randomised, and fully controlled scientifically, was conducted by doctors and scientists from Jikei University School of Medicine in Tokyo, Japan.
Note: For important articles from reliable sources on health issues, click here.
A Danish scientist who was a lead researcher in two studies that purport to show that mercury used in vaccines do not cause autism is believed to have used forged documents to steal $2 million from Aarhus University in Denmark. Dr. Poul Thorsen was also a research professor at Emory University from 2003 until June of 2009. Emory University officials gave no reason for Thorsen's departure. The Centers for Disease Control and Prevention funded research conducted by Thorsen and his colleagues at Aarhus University. The CDC asked the researchers to conduct studies to determine whether thimerosal, a mercury-based preservative and adjuvant used in vaccines, played any role in causing autism. The results of the studies, that there was no link between vaccines containing mercury and autism, formed the foundation for the conclusions of several Institute of Medicine reports. In a statement Aarhus University officials said Thorsen forged documents supposedly from the CDC to obtain the release of $2 million from the university. Autism advocacy groups are demanding his studies be given a closer look. Those same groups have long claimed that the results of the studies were suspect.
Note: Very few mainstream media covered this intriguing story of a key researcher whose work is held up to deny any link between vaccines and autism. Yet Robert F. Kennedy Jr. published a very revealing article on this key topic, which you can read here.
More than 1,000 people in New Jersey and New York, many of them adolescent Orthodox Jews, have been sickened with mumps since August, health authorities said Monday. Almost all of those infected with the virus are of the Orthodox or Hasidic Jewish population, and their average age is 14. The mumps outbreak began at a summer camp for Orthodox Jewish boys in Sullivan County, New York, according to the CDC. Health officials have linked the outbreak to an 11-year-old boy at the camp. He had recently returned from the United Kingdom, where a mumps outbreak had spread to 4,000 people. Rabbi Yehunda Pirutinsky was surprised when his 14-year-old son was diagnosed with mumps a week ago. "He was completely vaccinated," Pirutinsky said. "So it was a surprise to us he came down with mumps." Of the New Jersey cases, 77 percent were vaccinated, Terjesen said. But the vaccine is not 100 percent effective, according to the CDC. At two doses, the vaccine is 76 to 95 percent effective, the CDC says on its Web site.
Note: 77 percent of the over 1,000 who came down with mumps had been vaccinated against the disease, yet the CDC claims it is 76 to 95 percent effective. Hmmmm... For many reports from reliable sources that highlight serious problems with vaccines, click here.
More than half the scientists on the swine flu taskforce advising the [UK] Government have ties to drug companies. Eleven of the 20 members of the Scientific Advisory Group for Emergencies (SAGE) have done work for the pharmaceutical industry or are linked to it through their universities. Many have declared interests in GlaxoSmithKline, the vaccine maker expected to be the biggest beneficiary of the pandemic. The disclosure of the register of interests comes just days after a health expert branded the swine flu outbreak a 'false pandemic' driven by the drug companies which stood to profit. The Government is now trying to offload up to Ł1billion worth of unwanted swine flu vaccine. Last July, the Department of Health warned of up 65,000 deaths, with 350 a day at the pandemic's peak. But the death toll now stands at just 251. SAGE was created to give Ministers recommendations on how to control and treat the virus. Official documents show some members are linked to vaccine manufacturer Baxter and to Roche, which makes Tamiflu. GSK, Baxter and Roche stand to make up to Ł1.5billion between them from Government contracts related to swine flu.
Note: For lots more on the Swine Flu "false pandemic," click here.
Ministers are preparing to offload millions of unwanted swine flu vaccines, it has emerged, as officials predicted that there will be no third wave of the pandemic this winter. Millions of [dollars] could be wasted if the Government is unable to get out of orders for the vaccine it has placed with GlaxoSmithKline (GSK), the pharmaceutical giant. Officials confirmed that they are considering a number of options, including attempting to sell or give away millions of the vaccines. They also considering whether to stand down the National Pandemic Flu Service, the network of call centres which diagnose swine flu and hand out antiviral medications. In May, even before a pandemic had been declared, ministers had signed contracts thought to be worth around Ł100 million to deliver 90 million vaccines to Britain. Britain has now received almost 29 million doses of the H1N1 vaccine, but only just over 3.7 million have been given out and in total the Government has announced plans to inoculate only 14 million people.
Note: For a powerful insight into the corrupt symbiosis between pharmaceutical corporations and government, read this analysis by Marcia Angell, former editor of the New England Journal of Medicine. For lots more on the swine flu scare, click here.
Dr. Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention, was named president of Merck & Co Inc's vaccine division. Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia. She had led CDC from one crisis to another, including the investigation into the anthrax attacks that killed five people in 2001, the H5N1 avian influenza, the global outbreak of severe acute respiratory syndrome, or SARS, and various outbreaks of food poisoning. She may be charged with reigniting flagging sales of Merck's Gardasil vaccine to prevent cervical cancer by protecting against human papillomavirus or HPV. After an encouraging launch Gardasil sales have been falling and were down 22 percent in the third quarter at $311 million.
Note: So the head of the CDC now is in charge of vaccines at one of the biggest pharmaceutical companies in the world. Could this be considered conflict of interest? Could this possibly be payback for supporting the vaccine agenda so strongly for years? For more on the risks and dangers of vaccines, click here.
American special forces have conducted multiple clandestine raids into Pakistan's tribal areas as part of a secret war in the border region where Washington is pressing to expand its drone assassination programme. A former Nato officer said the incursions, only one of which has been previously reported, occurred between 2003 and 2008, involved helicopter-borne elite soldiers stealing across the border at night, and were never declared to the Pakistani government. "The Pakistanis were kept entirely in the dark about it. It was one of those things we wouldn't confirm officially with them," said the source, who had detailed knowledge of the operations. Such operations are a matter of sensitivity in Pakistan. While public opinion has grudgingly tolerated CIA-led drone strikes in the tribal areas, any hint of American "boots on the ground" is greeted with virulent condemnation. After the only publicly acknowledged special forces raid in September 2008, Pakistan's foreign office condemned it as "a grave provocation" while the military threatened retaliatory action. The military source said that was the fourth raid of previous years. The secretive nature of the raids underscores the suspicious nature of the relationship between the two allies as they argue about Washington's latest demands.
Note: For lots more from reliable sources on the secret realities of the "war on terrorism," click here.
A new report finds that the Centers for Disease Control and Prevention did a poor job of screening medical experts for financial conflicts when it hired them to advise the agency on vaccine safety. Most of the experts who served on advisory panels in 2007 to evaluate vaccines for flu and cervical cancer had potential conflicts that were never resolved, the report said. Some were legally barred from considering the issues but did so anyway. In the report ... Daniel R. Levinson, the inspector general of the Department of Health and Human Services, found that the centers failed nearly every time to ensure that the experts adequately filled out forms confirming they were not being paid by companies with an interest in their decisions. The report found that 64 percent of the advisers had potential conflicts of interest that were never identified or were left unresolved by the centers. Thirteen percent failed to have an appropriate conflicts form on file at the agency at all, which should have barred their participation in the meetings entirely, Mr. Levinson found. And 3 percent voted on matters that ethics officers had already barred them from considering.
Drug company GlaxoSmithKline has told Canadian doctors to stop using one lot of its H1N1 vaccine until an investigation into a higher-than-expected number of severe allergic reactions is completed. The U.S. vaccine will not be identical to Arepanrix, the GSK H1N1 vaccine used in Canada. Arepanrix contains an adjuvant, a substance designed to boost the immune response, but adjuvants have never been approved for use in U.S. flu vaccines. Almost all of the 172,000 doses in question, distributed the week of Nov. 2 to six Canadian provinces, already have been administered, said Geoffrey Matthews, a spokeswoman for the Public Health Agency of Canada, which, with GSK and Health Canada, is investigating cases of anaphylaxis. Symptoms of anaphylaxis include trouble breathing, chest tightness and swelling of the mouth and throat. Six cases have been reported, Matthews says. In the USA, the Vaccine Adverse Event Reporting System said that as of Nov. 13 it had received 116 reports of serious health events related to the vaccine, including eight deaths – similar to the number in previous years after a similar number of seasonal flu vaccine doses had been shipped.
Note: For lots more on the risks of swine flu vaccines, click here.
Although federal health officials decline to use the word "peaked," the current wave of swine flu appears to have done so in the United States. Flu activity is coming down in all regions of the country, the Centers for Disease Control and Prevention said Friday, though it is still rising in Hawaii, Maine and some isolated areas. The World Health Organization said Friday that there were "early signs of a peak" in much of the United States. On Wednesday, the American College Health Association, which surveys over 250 colleges with more than three million students, said new cases of flu had dropped in the week ending Nov. 13. It was the first drop since school resumed in the fall, and it was significant – new cases were down 27 percent from the week before. And on Friday, Quest Diagnostics, the country's largest laboratory, said its tests of 142,000 suspected flu specimens since May showed that the flu peaked in late October. Nonetheless, Dr. Anne Schuchat, the director of immunization and respiratory diseases at the C.D.C., chose her words carefully, saying: "I wish I knew if we had hit the peak. Even if a peak has occurred, half the people who are going to get sick haven't gotten sick yet." The drop was clearly not caused by the swine flu vaccine drive, which has not gone as fast as the authorities had hoped.
Note: Just like the avian flu scare a few years ago, the swine flu hype has turned out to be largely a whimper, yet the pharmaceutical companies are happy, as again they have made billions of dollars from the massive amonts of vaccines and drugs purchased by the government with your tax dollars. For more, click here and here.
As Germany launched its mass-vaccination program against the H1N1 flu virus on Monday, the government found itself fending off accusations of favoritism because it was offering one vaccine believed to have fewer side effects to civil servants, politicians and soldiers, and another, potentially riskier vaccine to everyone else. The German government prepared for its mass-vaccination campaign earlier this year by ordering 50 million doses of the Pandemrix vaccine. The vaccine, manufactured by GlaxoSmithKline, contains an immunity-enhancing chemical compound, known as an adjuvant, whose side effects are not yet entirely known. The Interior Ministry confirmed that it had ordered a different vaccine, Celvapan, for government officials and the military. Celvapan, which is made by U.S. pharmaceutical giant Baxter, does not contain an adjuvant and is believed to have fewer side effects.
Swiss drugmaker Novartis said sales would grow faster than expected this year, even without a shot in the arm of up to $700 million from its H1N1 swine flu pandemic vaccine. Third-quarter net profit at Novartis ... nudged up 1 percent to $2.1 billion. This year is turning out to be better than initially feared for Novartis and other major pharmaceutical companies, thanks to hefty price increases and windfall sales arising from the H1N1 outbreak. Both Pfizer, the world's biggest drugmaker, and Eli Lilly topped earnings forecasts this week. Roche reported a sharp jump in sales of its Tamiflu drug for flu last week and analysts expect GlaxoSmithKline's Relenza will also see strong sales in the third quarter. On the vaccine front, Glaxo, Sanofi-Aventis and AstraZeneca are all expected to highlight an expected jump in fourth-quarter sales due to swine flu. The H1N1 flu vaccine is expected to contribute about $400-700 million of sales in the fourth quarter.
Note: Donald Rumsfeld personally made millions as a direct result of the avian flu scare a few year ago. For more on this, click here. For more on pharmaceutical corporation profiteering from swine flu vaccines, click here.
Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business. Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market. "The vaccine market is booming," says Bruce Carlson, spokesperson at market research firm Kalorama, which publishes an annual survey of the vaccine industry. "It's an enormous growth area for pharmaceuticals at a time when other areas are not doing so well," he says. As always with pandemic flus, taxpayers are footing the $1.5 billion check for the 250 million swine flu vaccines that the government has ordered so far and will be distributing free to doctors, pharmacies and schools. In addition, Congress has set aside more than $10 billion this year to research flu viruses, monitor H1N1's progress and educate the public about prevention. Drugmakers pocket most of the revenues from flu sales. But some say it's not just drugmakers who stand to benefit. Doctors collect copayments for special office visits to inject shots, and there have been assertions that these doctors actually profit handsomely from these vaccinations. Pharmacies also charge co-payments or full price of about $25 to those without insurance.
Note: For a revealing article questioning the efficacy of vaccines, click here. And for a powerful CBS '60 Minutes' news clip clearly showing how the profit motive in vaccines endangers public health, click here.
A “perplexing” Canadian study linking H1N1 to seasonal flu shots is throwing national influenza plans into disarray and testing public faith in the government agencies responsible for protecting the nation's health. Distributed for peer review last week, the study confounded infectious-disease experts in suggesting that people vaccinated against seasonal flu are twice as likely to catch swine flu. The paper has since convinced several provincial health agencies to announce hasty suspensions of seasonal flu vaccinations, long-held fixtures of public-health planning. “It has confused things very badly,” said Dr. Ethan Rubinstein, head of adult infectious diseases at the University of Manitoba. “And it has certainly cost us credibility from the public because of conflicting recommendations. Until last week, there had always been much encouragement to get the seasonal flu vaccine.” On Sunday Quebec joined Alberta, Saskatchewan, Ontario and Nova Scotia in suspending seasonal flu shots for anyone under 65 years of age. Quebec's Health Ministry announced it would postpone vaccinations until January. B.C. is expected to announce a similar suspension during a press conference Monday morning. Other provinces, including Manitoba, are still pondering a response to the research. Dr. Rubinstein, who has read the study, said it appears sound. “There are a large number of authors, all of them excellent and credible researchers,” he said. “And the sample size is very large – 12 or 13 million people taken from the central reporting systems in three provinces. The research is solid.”
Note: For lots more from reliable sources on the dangers of vaccines, click here.
As a group of healthcare workers, we are being mandated by a new New York state law to receive the seasonal flu vaccine and H1N1 vaccines. If we do not receive these vaccines by November 30th, that inaction is to be considered our resignation. We must sign a consent for the vaccines prior to their administration. The manufacturers have been granted immunity by the government; they cannot be sued for untoward effects. We do not want to receive these vaccines. Our educated studies of risks versus benefits conclude that the risks of the vaccine are greater than the possible benefits. All health care workers with direct patient care are mandated to receive the vaccine, so the coercion is real -- we cannot just go find a job "somewhere else." And the job market of 2009 does not offer opportunity in a different arena where we could still feed our families. We understand the fear that swine flu and influenza has generated. While our sources of information indicate that swine flu is not a pandemic, we know that the slanted research fed by the media offers results intended to frighten the public. We do not have the power to stop the fear that mass hype is able to generate. We hear the hype you are fed. We do not want to bring you harm, but we should not be forced into harm's way ourselves.
Note: For more on mandatory flu vaccinations, click here.
Health care workers are planning to take to the streets Tuesday at a rally in front of the Albany, N.Y. state capitol to protest mandatory vaccination. The rally is intended to call for "freedom of choice in vaccination and health care" and to protest mandatory vaccination for influenza and the H1N1 swine flu. "This vaccine has not been clinically tested to the same degree as the regular flu vaccine," Tara Accavallo, a registered nurse on Long Island, told Newsday. "If something happens to me, if I get seriously injured from this vaccine, who's going to help me?" While physicians, nurses, and medical technicians may not be known for their willingness to march on state capitols, a recent New York Department of Health requirement has sparked an unusually intense response. The August 13 regulations say that all health care workers who "could potentially expose patients" must be vaccinated for influenza by November 30 unless it would be "detrimental" to the recipient's health. This raises an obvious and important question: Under what circumstances can government officials order mandatory vaccination? And could the general public be ordered to roll up their sleeves for injections, even if there might be side effects beyond a sore arm or mild fever? The concern in New York also comes as skepticism of vaccination in general seems to be on the rise.
Note: For more on this protest, click here. Note that the U.S. government has granted immunity from lawsuits to the drug companies manufacturing the vaccines. So who will be responsible if there is a repeat of the 1976 swine flu vaccination campaign, where hundreds died and thousands were paralyzed by the vaccines?
U.S. military troops will begin getting required swine flu shots in the next week to 10 days, with active duty forces deploying to war zones and other critical areas going to the front of the vaccine line. Air Force Gen. Gene Renuart also [said] that as many as 400 troops are ready to go to five regional headquarters around the country to assist federal health and emergency management officials. The Pentagon has bought 2.7 million vaccines, and 1.4 million of those will go to active duty military. National Guard troops on active duty are also required to receive the vaccine, as are civilian Defense Department employees who are in critical jobs. "Because I can compel people to get the shots, larger numbers will have the vaccine," said Renuart, commander of U.S. Northern Command. "They will, as a percentage of the population, be vaccinated more rapidly than many of us. So we may see some objective results, good or not, of the vaccinations." Shots will be doled out on a priority basis, with troops preparing to deploy first, followed by other active duty forces, particularly any who might be needed to quickly respond to a hurricane or other emergency. Inoculating the military is a key requirement of the Pentagon's emergency plan, as a way to ensure that troops are available to protect the nation. They also will be on tap to provide help to states if problems come up as the flu season continues.
Note: It is not made clear by this article precisely how military personnel will "assist" civilian authorities handle a mass swine flue vaccination program. The plans to use the military for this purpose are unprecedented and formerly illegal. For lots more from reliable sources on the dangers of vaccines, click here and here.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.